Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Net Cash Flow: 2017-2024

Historic Net Cash Flow for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $353.8 million.

  • Bicycle Therapeutics' Net Cash Flow rose 0.44% to -$71.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$241.8 million, marking a year-over-year decrease of 176.42%. This contributed to the annual value of $353.8 million for FY2024, which is 89.73% up from last year.
  • As of FY2024, Bicycle Therapeutics' Net Cash Flow stood at $353.8 million, which was up 89.73% from $186.5 million recorded in FY2023.
  • Bicycle Therapeutics' Net Cash Flow's 5-year high stood at $353.8 million during FY2024, with a 5-year trough of -$98.4 million in FY2022.
  • Its 3-year average for Net Cash Flow is $147.3 million, with a median of $186.5 million in 2023.
  • As far as peak fluctuations go, Bicycle Therapeutics' Net Cash Flow skyrocketed by 592.98% in 2021, and later tumbled by 132.38% in 2022.
  • Over the past 5 years, Bicycle Therapeutics' Net Cash Flow (Yearly) stood at $43.9 million in 2020, then soared by 592.98% to $303.9 million in 2021, then slumped by 132.38% to -$98.4 million in 2022, then soared by 289.49% to $186.5 million in 2023, then surged by 89.73% to $353.8 million in 2024.